Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / T••• T•••••••••

A•••••••• C•••••• P••••••• Acquires T••• T•••••••••

Platform acquisitionannouncedannounced Nov 25, 2024Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
transportation_logistics / supply chain
Target location
TN, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
8 named
Buy side
  • “As the last five years have demonstrated, global supply chains are not nearly as fortified as they need to be, particularly in medical device manufacturing,” said Matt A•••••, a Managing Partner at A•••••••• C•••••• P•••••••.
  • A•••••••• C•••••• P••••••• Acquires T••• T••••••••• | published on A•••••••• C•••••• P•••••••'s own news page arlingtoncap.com
Advisory side
  • H••••• W•••••••Buy-side adviserconfirmed
    H••••• W••••••• served as financial advisor and G•••••• P•••••• LLP served as legal advisor to A•••••••• C•••••• P•••••••.
  • G•••••• P••••••Legal adviserconfirmed
    H••••• W••••••• served as financial advisor and G•••••• P•••••• LLP served as legal advisor to A•••••••• C•••••• P•••••••.
  • C•••••• L••Legal adviserconfirmed
    Kirkland & Ellis LLP and Massumi + C•••••• provided legal counsel to T••• T••••••••• and Clearlake.
  • R••• B••••Sell-side adviserconfirmed
    R••• B•••• acted as financial advisor to T••• T•••••••••.
Side not stated
  • “The medical device manufacturing industry is incredibly complex, but we feel fortunate to partner with A•••••••• in our next chapter,” said M••••••• W••••, CEO of T••• Tech.
  • A•••••••• C•••••• P••••••• Acquires T••• T•••••••••
Evidence
A•••••••• C•••••• P••••••• Acquires T••• T•••••••••
A•••••••• C•••••• P••••••• Acquires T••• T••••••••• | Private Equity Intelligence | DFX